These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4073090)

  • 61. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
    Pankey GA; Katner HP; Valainis GT; Clarkson MJ; Cortez LM; Dalovisio JR
    Am J Med; 1985 Nov; 79(5B):106-15. PubMed ID: 4073076
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteomyelitis and septic arthritis caused by Haemophilus influenzae, type f, in a young girl.
    Chusid MJ; Schneider JP; Thometz JG; Dunne WM
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):157-9. PubMed ID: 1572141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of timentin in the treatment of female pelvic soft tissue infections.
    Faro S
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):80S-83S. PubMed ID: 2041836
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Beta-lactam therapy of osteomyelitis and septic arthritis.
    Wilber RB
    Scand J Infect Dis Suppl; 1984; 42():155-68. PubMed ID: 6396837
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS; Danziger LH
    Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic experience with ticarcillin disodium plus potassium clavulanate in the Federal Republic of Germany--results of a multicentre-study.
    Heilmann HD
    Int J Clin Pharmacol Res; 1987; 7(3):233-7. PubMed ID: 3596864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
    Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
    Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of ticarcillin disodium plus clavulanate potassium in the management of acute bacterial infections in children.
    Gooch WM; Swenson E; Higbee MD
    Am J Med; 1985 Nov; 79(5B):184-7. PubMed ID: 4073089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin).
    Manek N; Wise R; Donovan IA
    J Antimicrob Chemother; 1987 Mar; 19(3):363-6. PubMed ID: 3494723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B; Chanal M; Sirot D; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prophylactic use of ticarcillin/clavulanate in the neonate.
    Fayed SB; Sutton AM; Turner TL; McAllister TA
    J Antimicrob Chemother; 1987 Jan; 19(1):113-8. PubMed ID: 3558165
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ticarcillin/clavulanate for the treatment of female genital tract infections. Efficacy, safety and comparative microbiology.
    McGregor JA
    J Reprod Med; 1990 Mar; 35(3 Suppl):333-8. PubMed ID: 2319515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ticarcillin/clavulanate in severe infections in patients with varying renal function.
    Dalet F; del Rio G; Torrellas A
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():131-9. PubMed ID: 2606815
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
    Holloway WJ
    Am J Med; 1985 Nov; 79(5B):168-71. PubMed ID: 4073086
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further observations of the role of timentin in clinical practice.
    Shah A; Madhavan T; Drelichman V; Price J
    J Chemother; 1989 Jul; 1(4 Suppl):656-7. PubMed ID: 16312578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.